Has Canada’s biotech moment finally arrived?
From the moment AbCellera Biologics Inc. went public in late 2020, chief executive Carl Hansen’s goal was to build the antibody developer into Canada’s first homegrown Big Pharma giant. But since its explosive Nasdaq debut – Vancouver-based AbCellera was …